Article
Dual transgenesis of T cells with a CD44v6-specific chimeric antigen receptor and a suicide gene for the safe eradication of chemoresistant leukaemia and myeloma
2012-01-01
Abstract excerpt
The recent and extraordinaire clinical successes of T cells modified with chimeric antigen receptors (CAR) against B-cell tumours indicate this strategy as the new frontier for the immunotherapy of haematological malignancies. In this study, we investigated a new CAR-based strategy for the treatment of acute myeloid leukaemia (AML) and multiple myeloma (MM). The ultimate goal of cancer treatment is the elimination...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b97c980e-5882-52a3-a724-c1970eb9cdd5
- DOI
- 10.21954/ou.ro.0000ffd2
